Research Topic

The Effects of Mitochondrial Dysfunction on the Cell Cycle

About this Research Topic

Mitochondria have many functions in addition to their canonical metabolic role of energy generation. Mitochondria exist in dynamic networks and their non-canonical roles include (but are not limited to) regulation of the cell cycle, intracellular calcium homeostasis, and apoptosis. In rapidly proliferating cells, mitochondria divide in coordination with nuclear division, a process called mitotic fission. Therefore, acquired dysfunctions of mitochondrial metabolism and dynamics (such as increased mitochondrial fission and reduced fusion) contribute to rapid cell cycle progression leading to hyperproliferative pathologies, such as cancers and pulmonary arterial hypertension, a benign cardiopulmonary disease.


Mitochondrial abnormalities in these diseases include increased pyruvate dehydrogenase kinase (PDK) and pyruvate kinase muscle isoform 2 (PKM2) expression, which in turn increase uncoupled glycolysis (the Warburg phenomenon). Warburg metabolism sustains energy homeostasis by the inhibition of oxidative metabolism that reduces mitochondrial apoptosis, allowing unchecked cell accumulation.


Furthermore, dysregulation of intramitochondrial Ca2+ due to epigenetic dysregulation of the mitochondrial calcium uniporter complex (MCUC) links the Warburg phenomenon to mitochondrial dynamics. Finally, targeting mitochondrial metabolism by promoting glucose oxidation, restoring fission/fusion balance, and regulating intramitochondrial calcium are promising therapeutic targets against hyperproliferative diseases.


The goal of this Research Topic is to help highlight research focusing on the effect of mitochondrial dynamics and metabolism on cell cycle regulation. In particular, studies identifying mitochondrial fission proteins (Drp1 and its binding partners) that may regulate cell cycle progression in health and in disease states are of particular interest. Also, we welcome submissions that help identify the relative importance of the mitochondrial fusion proteins (mitofusin isoforms) in regulating cell cycle progression in hyperproliferative diseases


Areas to be covered in this Research Topic may include, but are not limited to:

- Mediators of mitochondrial dynamics and diseases (Review Articles)
- Mitochondrial dynamics and cell division (Original Research Articles)
- Intramitochondrial calcium regulation in cell division (Original Research Articles)
- Mitochondrial regulation of the cytoskeleton in cell division (Review Articles)
- Effect of cell cycle inhibitors on mitochondrial dynamics (Review articles)
- Novel inhibitors and agonists of fission and fusion mediators to facilitate experimental therapeutics against hyperproliferative diseases (Original Research Articles)


Keywords: Mitochondria, cell cycle, mitotic fission, mitochondrial fusion, mitochondrial fission, hyperproliferative pathologies, cancer, pulmonary arterial hypertension


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Mitochondria have many functions in addition to their canonical metabolic role of energy generation. Mitochondria exist in dynamic networks and their non-canonical roles include (but are not limited to) regulation of the cell cycle, intracellular calcium homeostasis, and apoptosis. In rapidly proliferating cells, mitochondria divide in coordination with nuclear division, a process called mitotic fission. Therefore, acquired dysfunctions of mitochondrial metabolism and dynamics (such as increased mitochondrial fission and reduced fusion) contribute to rapid cell cycle progression leading to hyperproliferative pathologies, such as cancers and pulmonary arterial hypertension, a benign cardiopulmonary disease.


Mitochondrial abnormalities in these diseases include increased pyruvate dehydrogenase kinase (PDK) and pyruvate kinase muscle isoform 2 (PKM2) expression, which in turn increase uncoupled glycolysis (the Warburg phenomenon). Warburg metabolism sustains energy homeostasis by the inhibition of oxidative metabolism that reduces mitochondrial apoptosis, allowing unchecked cell accumulation.


Furthermore, dysregulation of intramitochondrial Ca2+ due to epigenetic dysregulation of the mitochondrial calcium uniporter complex (MCUC) links the Warburg phenomenon to mitochondrial dynamics. Finally, targeting mitochondrial metabolism by promoting glucose oxidation, restoring fission/fusion balance, and regulating intramitochondrial calcium are promising therapeutic targets against hyperproliferative diseases.


The goal of this Research Topic is to help highlight research focusing on the effect of mitochondrial dynamics and metabolism on cell cycle regulation. In particular, studies identifying mitochondrial fission proteins (Drp1 and its binding partners) that may regulate cell cycle progression in health and in disease states are of particular interest. Also, we welcome submissions that help identify the relative importance of the mitochondrial fusion proteins (mitofusin isoforms) in regulating cell cycle progression in hyperproliferative diseases


Areas to be covered in this Research Topic may include, but are not limited to:

- Mediators of mitochondrial dynamics and diseases (Review Articles)
- Mitochondrial dynamics and cell division (Original Research Articles)
- Intramitochondrial calcium regulation in cell division (Original Research Articles)
- Mitochondrial regulation of the cytoskeleton in cell division (Review Articles)
- Effect of cell cycle inhibitors on mitochondrial dynamics (Review articles)
- Novel inhibitors and agonists of fission and fusion mediators to facilitate experimental therapeutics against hyperproliferative diseases (Original Research Articles)


Keywords: Mitochondria, cell cycle, mitotic fission, mitochondrial fusion, mitochondrial fission, hyperproliferative pathologies, cancer, pulmonary arterial hypertension


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

30 September 2021 Abstract
28 February 2022 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

30 September 2021 Abstract
28 February 2022 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..